Lidocaine Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Lidocaine Cream
Generic name: LIDOCAINE
Manufacturer: InvaDerm Corporation
Product type: HUMAN OTC DRUG
SPL set ID: 5a7273d1-1dbc-420e-e063-6294a90a8629
SPL ID: 5a727400-ef10-23e5-e063-6394a90aec25
Version: 1
Effective date: 2026-09-01
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:56:21

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		Lidocaine Cream	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		InvaDerm Corporation	openfda.manufacturer_name
ndc	package	71457-525-30	openfda.package_ndc
ndc	package	71457-525-15	openfda.package_ndc
ndc	product	71457-525	openfda.product_ndc
ndc11	package	71457052530	derived:openfda.package_ndc
ndc11	package	71457052515	derived:openfda.package_ndc
rxcui		1366789	openfda.rxcui
spl id		5a727400-ef10-23e5-e063-6394a90aec25	id
spl set id		5a7273d1-1dbc-420e-e063-6294a90a8629	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings When using this product avoid contact with eyes do not exceed recommended dosage unless directed by a doctor Stop use and ask a doctor if rectal bleeding occurs condition worsens or does not improve within 7 days allergic reaction occurs redness, irritation, swelling, pain or other symptoms begin or increase symptoms clear up and return within a few days

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.